Lundbeck Taps Ex-Novo Nordisk CEO Jørgensen as Next Board Chair
Valby, Denmark – October 18, 2026 -- H. Lundbeck A/S plans to install former Novo Nordisk CEO Lars Fruergaard Jørgensen as Chair of its Board after the 2027 Annual General Meeting (AGM), succeeding Dorothea Wenzel, who will step down at that meeting.
Jørgensen joins the Board as observer on 10 November 2026
Jørgensen will take an observer seat on 10 November 2026 and will remain in that role until the AGM 2027. At that meeting he is expected to be formally elected as a Board member, subject to shareholder approval. The Board intends to elect him Chair thereafter. Nominated candidates will be listed in the notice convening the AGM 2027.